Hims & Hers Health Surges to 14th Most Traded Stock with $47.18 Billion Volume

On May 13, 2025, Hims & Hers Health (HIMS) experienced a significant surge, with its trading volume reaching $47.18 billion, marking a 41.84% increase from the previous day. This surge positioned Hims as the 14th most traded stock of the day, reflecting a strong market interest in the company's recent developments.

Hims & Hers Health issued $1 billion in senior unsecured notes, which are equal in payment rights to the company's existing and future senior notes. This move is part of the company's strategy to raise capital for various initiatives, including global expansion and technological advancements.

Hims & Hers Health reported impressive first-quarter earnings, with revenue reaching $586 million, more than double the figure from the previous year. This substantial growth was driven by a 38% increase in subscribers, bringing the total to 2.4 million active users. The company's earnings per share (EPS) of 20 cents also surpassed analyst expectations of 12 cents.

Despite issuing a conservative second-quarter revenue forecast of $530–$550 million, which is below Wall Street’s estimate of $564.6 million, Hims & Hers reaffirmed its full-year guidance. The company has set an ambitious target of achieving $6.5 billion in annual revenue by 2030, indicating its confidence in sustained growth.

Hims & Hers Health announced an upsized $870 million convertible senior note offering due in 2030. The proceeds from this offering will be used to accelerate global expansion, enhance technology infrastructure, and pursue strategic acquisitions. The notes carry a conversion price of $70.67, a 37.5% premium to the May 8 closing price of $51.40, and feature capped call transactions to minimize dilution for shareholders.

Hims & Hers Health's collaboration with Novo Nordisk has further boosted investor confidence. The company's market capitalization stands at $12.36 billion, with a P/E ratio of 125.54 and a beta of 1.84. This collaboration is expected to drive further growth and innovation in the telehealth and wellness sector.